Cheryl Nissen

520 total citations
10 papers, 446 citations indexed

About

Cheryl Nissen is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Biochemistry. According to data from OpenAlex, Cheryl Nissen has authored 10 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Endocrine and Autonomic Systems and 4 papers in Biochemistry. Recurrent topics in Cheryl Nissen's work include Neuropeptides and Animal Physiology (4 papers), Neuroscience of respiration and sleep (4 papers) and Macrophage Migration Inhibitory Factor (3 papers). Cheryl Nissen is often cited by papers focused on Neuropeptides and Animal Physiology (4 papers), Neuroscience of respiration and sleep (4 papers) and Macrophage Migration Inhibitory Factor (3 papers). Cheryl Nissen collaborates with scholars based in United States and Hungary. Cheryl Nissen's co-authors include Abba J. Kastin, David H. Coy, Andrew V. Schally, István Teplán, Károly Nikolics, Abba J. Kastin, William A. Banks, Paul F. Castellanos, Richard D. Olson and Rudolph H. Ehrensing and has published in prestigious journals such as Pharmacology Biochemistry and Behavior, Neuroendocrinology and Brain Research Bulletin.

In The Last Decade

Cheryl Nissen

10 papers receiving 418 citations

Peers

Cheryl Nissen
Matthew J. Gerdin United States
Karine Jeanneau Switzerland
A. Verhofstad Netherlands
John M. Farah United States
Marie Cahir United Kingdom
Jackie Meakin United Kingdom
Matthew J. Gerdin United States
Cheryl Nissen
Citations per year, relative to Cheryl Nissen Cheryl Nissen (= 1×) peers Matthew J. Gerdin

Countries citing papers authored by Cheryl Nissen

Since Specialization
Citations

This map shows the geographic impact of Cheryl Nissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Nissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Nissen more than expected).

Fields of papers citing papers by Cheryl Nissen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Nissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Nissen. The network helps show where Cheryl Nissen may publish in the future.

Co-authorship network of co-authors of Cheryl Nissen

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Nissen. A scholar is included among the top collaborators of Cheryl Nissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Nissen. Cheryl Nissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kastin, Abba J., Cheryl Nissen, & Richard D. Olson. (1982). Failure of MIF-1 or naloxone to reverse ischemic-induced neurologic deficits in gerbils. Pharmacology Biochemistry and Behavior. 17(5). 1083–1085. 22 indexed citations
2.
Kastin, Abba J., William A. Banks, Paul F. Castellanos, Cheryl Nissen, & David H. Coy. (1982). Differential penetration of DSIP peptides into rat brain. Pharmacology Biochemistry and Behavior. 17(6). 1187–1191. 38 indexed citations
3.
Kastin, Abba J., Cheryl Nissen, & David H. Coy. (1981). Permeability of blood-brain barrier to DSIP peptides. Pharmacology Biochemistry and Behavior. 15(6). 955–959. 40 indexed citations
4.
Kastin, Abba J., Cheryl Nissen, & David H. Coy. (1981). DSIP-like immunoreactivity in the developing rat brain. Brain Research Bulletin. 7(6). 687–690. 9 indexed citations
5.
Kastin, Abba J., Cheryl Nissen, James E. Zadina, Andrew V. Schally, & Rudolph H. Ehrensing. (1980). Naloxone-like actions of MIF-1 do not require the presence of the pituitary. Pharmacology Biochemistry and Behavior. 13(6). 907–912. 30 indexed citations
6.
Kastin, Abba J., Cheryl Nissen, Andrew V. Schally, & David H. Coy. (1979). Additional evidence that small amounts of a peptide can cross the blood-brain barrier. Pharmacology Biochemistry and Behavior. 11(6). 717–719. 74 indexed citations
7.
Kastin, Abba J., Cheryl Nissen, Andrew V. Schally, & David H. Coy. (1978). Radioimmunoassay of DSIP-like material in rat brain. Brain Research Bulletin. 3(6). 691–695. 50 indexed citations
8.
Kastin, Abba J., Cheryl Nissen, Andrew V. Schally, & David H. Coy. (1976). Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain Research Bulletin. 1(6). 583–589. 81 indexed citations
9.
Kastin, Abba J., Cheryl Nissen, Károly Nikolics, et al.. (1976). Distribution of 3H-α-MSH in rat brain. Brain Research Bulletin. 1(1). 19–26. 96 indexed citations
10.
Kastin, Abba J., Cheryl Nissen, Tommie W. Redding, R.M.G. Nair, & Andrew V. Schally. (1974). Delayed Disappearance of <sup>14</sup>C-Labeled-Pro-Leu-Gly-NH<sub>2</sub> From the Blood of Hypophysectomized Rats. Neuroendocrinology. 16(1). 36–42. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026